Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Hepatic HIF2 is a key determinant of manganese excess and polycythemia in SLC30A10 deficiency
Milankumar Prajapati, … , Mariam Aghajan, Thomas B. Bartnikas
Milankumar Prajapati, … , Mariam Aghajan, Thomas B. Bartnikas
Published April 23, 2024
Citation Information: JCI Insight. 2024;9(10):e169738. https://doi.org/10.1172/jci.insight.169738.
View: Text | PDF
Research Article Genetics Hepatology

Hepatic HIF2 is a key determinant of manganese excess and polycythemia in SLC30A10 deficiency

  • Text
  • PDF
Abstract

Manganese is an essential yet potentially toxic metal. Initially reported in 2012, mutations in SLC30A10 are the first known inherited cause of manganese excess. SLC30A10 is an apical membrane protein that exports manganese from hepatocytes into bile and from enterocytes into the lumen of the gastrointestinal tract. SLC30A10 deficiency results in impaired gastrointestinal manganese excretion, leading to manganese excess, neurologic deficits, liver cirrhosis, polycythemia, and erythropoietin excess. Neurologic and liver disease are attributed to manganese toxicity. Polycythemia is attributed to erythropoietin excess. The goal of this study was to determine the basis of erythropoietin excess in SLC30A10 deficiency. Here, we demonstrate that transcription factors hypoxia-inducible factor 1a (Hif1a) and 2a (Hif2a), key mediators of the cellular response to hypoxia, are both upregulated in livers of Slc30a10-deficient mice. Hepatic Hif2a deficiency corrected erythropoietin expression and polycythemia and attenuated aberrant hepatic gene expression in Slc30a10-deficient mice, while hepatic Hif1a deficiency had no discernible impact. Hepatic Hif2a deficiency also attenuated manganese excess, though the underlying cause of this is not clear at this time. Overall, our results indicate that hepatic HIF2 is a key determinant of pathophysiology in SLC30A10 deficiency and expand our understanding of the contribution of HIFs to human disease.

Authors

Milankumar Prajapati, Jared Z. Zhang, Lauren Chiu, Grace S. Chong, Courtney J. Mercadante, Heather L. Kowalski, Bradley Delaney, Jessica A. Anderson, Shuling Guo, Mariam Aghajan, Thomas B. Bartnikas

×

Figure 9

Hepatocyte Hif2a deficiency attenuates differential gene expression in livers of Slc30a10–/– mice.

Options: View larger image (or click on image) Download as PowerPoint
Hepatocyte Hif2a deficiency attenuates differential gene expression in l...
Bulk RNA-Seq was performed on livers from 2-month-old Slc30a10–/– Hif2afl/fl Alb and Slc30a10–/– Hif2afl/fl mice. Two females and 2 males were analyzed per genotype. (A) Volcano plot. Differentially expressed genes [adjusted P < 0.05 and absolute value of log2(fold-change) > 1] are shown as light orange points with gene names shown adjacent as space permitted; nondifferentially expressed genes are shown as blue points; x,y coordinates of additional genes of interest are shown in smaller box. Genes with log2(fold-change) < 0 are more abundantly expressed in first group listed in box at top of plot; genes with log2(fold-change) > 0 are more abundantly expressed in second group listed. (B) Genes differentially expressed with Slc30a10 deficiency and genes differentially expressed with hepatic Hif2a deficiency in Slc30a10-deficient mice were compared with Venn diagrams and gene pathway enrichment.

Copyright © 2025 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts